KANJINTI 150 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
KANJINTI 150 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Commercialized
Register Number
1181281001
Prescription Type
Uso Hospitalario
Authorization Date
May 28, 2018
Dosage Form
POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Route: VÍA INTRAVENOSA
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number1181281001
EMA Approved
Yes
Drug Classification
✗
Generic
No
✗
Orphan
No
✓
Biosimilar
Yes
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (1)
TRASTUZUMABActive
Quantity: 156 mg
Name: TRASTUZUMAB
ATC CLASSIFICATION (3)
L01F
L01FD
L01FD01